🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,867 results for “De” Clear

  1. Ursodeoxycholic acid combined with total glucosides of paeony

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis

    approved small molecule active

    1 trial

  2. Use of an Implantable Loop Recorder

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial

  3. VENLAFAXINE

    Disc Medicine

    Major Depressive Disorder

    approved small molecule active

    1 trial

  4. VERAPAMIL , NEBIVOLOL , PROPAFENONE , BISOPROLOL , AMIODARONE , FLECAINIDE , SOTALOL , DILTIAZEM

    Pari Pharma GmbH

    Asymptomatic Patients with frequent PVCs and normal LVEF

    approved small molecule active

    1 trial

  5. Vabysmo 120 mg/mL solution for injection

    Hoffmann-La Roche

    Neovascular Age-Related Macular Degeneration

    approved small molecule active

    1 trial

  6. Vaicella Vaccine+DTaP on Day 0, MMR on Day 30

    Sinovac Research and Development Co.,

    Varicella (chickenpox)

    approved mab active

    1 trial

  7. Vardenafil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Erectile Dysfunction

    approved small molecule active

    1 trial

  8. Varicella vaccine

    Sinovac Research and Development Co.,

    VZV

    approved mab completed

    1 trial

  9. Varicella vaccine+TIV

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial

  10. Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geïnactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    healthy individuals

    approved small molecule active

    1 trial

  11. Vedolizumab

    Takeda

    Moderately to Severely Active Crohn's Disease

    approved mab active

    1 trial

  12. Video directly observed therapy with contingency management

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other active

    1 trial

  13. Vitamine E-400 complex, Microgynon 30, 0,15 mg/0,03 mg omhulde tabletten

    Disc Medicine

    Migraine

    approved small molecule active

    1 trial

  14. Vortioxetine

    Takeda

    Unipolar Major Depression

    approved small molecule terminated

    1 trial

  15. Vortioxetine

    Takeda

    Depressive Disorder

    approved small molecule terminated

    1 trial

  16. Vortioxetine 10 mg

    Takeda

    Age-related Cognitive Decline

    approved small molecule completed

    1 trial

  17. Vyvanse (lisdexamfetamine dimesylate)

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  18. WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL

    Fondazione Telethon ETS

    Myocardial infarction with non-obstructive coronary arteries (MINOCA)

    approved small molecule active

    1 trial

  19. Wangbi granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  20. Warfarin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anticoagulation

    approved small molecule active

    1 trial

  21. Wen Xin granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  22. XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules

    Pfizer Australia Pty Ltd

    This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed

    approved small molecule active

    1 trial

  23. XR-B (SUBLOCADETM)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    approved small molecule completed

    1 trial

  24. Xiang Sha Liu Jun Zi Decoction dry powder

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources